Castle Biosciences' Receivables - Net fell 154.99% to $49.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $49.5 million, marking a year-over-year decrease of 154.99%. This contributed to the annual value of $51.2 million for FY2024, which is 3372.15% up from last year.
Castle Biosciences' Receivables - Net amounted to $49.5 million in Q3 2025, which was down 154.99% from $52.3 million recorded in Q2 2025.
Castle Biosciences' Receivables - Net's 5-year high stood at $56.4 million during Q1 2025, with a 5-year trough of $14.3 million in Q1 2021.
Its 5-year average for Receivables - Net is $33.7 million, with a median of $31.3 million in 2023.
Per our database at Business Quant, Castle Biosciences' Receivables - Net crashed by 210.96% in 2021 and then surged by 6315.39% in 2023.
Quarter analysis of 5 years shows Castle Biosciences' Receivables - Net stood at $17.3 million in 2021, then soared by 35.84% to $23.5 million in 2022, then soared by 63.15% to $38.3 million in 2023, then skyrocketed by 33.72% to $51.2 million in 2024, then decreased by 3.39% to $49.5 million in 2025.
Its Receivables - Net stands at $49.5 million for Q3 2025, versus $52.3 million for Q2 2025 and $56.4 million for Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value